Filana Therapeutics, Inc.
MX ˙ BMV ˙ US14817C1071
SecurityMX:FLNA / Filana Therapeutics, Inc.
InstitutionWalleye Trading LLC
Latest Disclosed Ownership20,968 shares
Latest Disclosed Value $ 35,436
Walleye Trading LLC ownership in FLNA / Filana Therapeutics, Inc.

On May 8, 2026 - Walleye Trading LLC filed a 13F-HR form disclosing ownership of 20,968 shares of Filana Therapeutics, Inc. (MX:FLNA) valued at $35,436 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 9,178 shares of Filana Therapeutics, Inc.. This represents a change in shares of 128.46% during the quarter.

Walleye Trading LLC has a history of taking positions in derivatives of the underlying security (FLNA) in the form of stock options. The firm currently holds call options representing 50,600 of underlying shares valued at $85,514 USD and put options representing 63,800 of underlying shares valued at $107,822 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

MX:FLNA / Filana Therapeutics, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-08 2026-03-31 13F FILANA THERAPEUTICS COM 14817C107 20,968 11,790 128.46 35 94.44 0.0001
2026-02-13 2025-12-31 13F CASSAVA SCIENCES COM 14817C107 9,178 -26,475 -74.26 18 -82.52 0.0000
2025-11-14 2025-09-30 13F CASSAVA SCIENCES COM 14817C107 35,653 16,484 85.99 104 202.94 0.0002
2025-08-13 2025-06-30 13F CASSAVA SCIENCES COM 14817C107 19,169 -23,726 -55.31 35 -46.87 0.0001
2025-05-14 2025-03-31 13F CASSAVA SCIENCES COM 14817C107 42,895 42,895 64 0.0001
2024-11-14 2024-09-30 13F CASSAVA SCIENCES COM 14817C107 0 -3,985 -100.00 0 -100.00
2024-08-14 2024-06-30 13F CASSAVA SCIENCES COM 14817C107 3,985 3,985 49 0.0001
2023-11-21 2023-09-30 13F/A-1 CASSAVA SCIENCES COM 14817C107 0 -27,009 -100.00 0 -100.00
2023-11-14 2023-09-30 13F CASSAVA SCIENCES COM 14817C107 0 -27,009 0
2023-08-14 2023-06-30 13F CASSAVA SCIENCES COM 14817C107 27,009 27,009 662 0.0020
2021-08-16 2021-06-30 13F CASSAVA SCIENCES COM 14817C107 0 -348 -100.00 0 -100.00
2021-05-17 2021-03-31 13F CASSAVA SCIENCES COM 14817C107 348 348 16 0.0001
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-08 2026-03-31 13F FILANA THERAPEUTICS COM Call 50,600 -74.47 86 -78.32 n/a n/a n/a
2026-02-13 2025-12-31 13F CASSAVA SCIENCES COM Call 198,200 9.81 392 -25.33 n/a n/a n/a
2025-11-14 2025-09-30 13F CASSAVA SCIENCES COM Call 180,500 33.11 525 114.29 n/a n/a n/a
2025-08-13 2025-06-30 13F CASSAVA SCIENCES COM Call 135,600 -9.66 245 8.89 n/a n/a n/a
2025-05-14 2025-03-31 13F CASSAVA SCIENCES COM Call 150,100 -44.39 225 -64.62 n/a n/a n/a
2025-02-13 2024-12-31 13F CASSAVA SCIENCES COM Call 269,900 136.34 637 -81.07 n/a n/a n/a
2024-11-14 2024-09-30 13F CASSAVA SCIENCES COM Call 114,200 -7.98 3,361 119.32 n/a n/a n/a
2024-08-14 2024-06-30 13F CASSAVA SCIENCES COM Call 124,100 2.31 1,533 -37.75 n/a n/a n/a
2024-05-15 2024-03-31 13F CASSAVA SCIENCES COM Call 121,300 -25.17 2,461 -32.54 n/a n/a n/a
2024-02-14 2023-12-31 13F CASSAVA SCIENCES COM Call 162,100 75.43 3,649 137.35 n/a n/a n/a
2023-11-21 2023-09-30 13F/A CASSAVA SCIENCES COM Call 92,400 569.57 1,538 354.73 n/a n/a n/a
2023-11-14 2023-09-30 13F CASSAVA SCIENCES COM Call 92,400 1,538 n/a n/a n/a
2023-08-14 2023-06-30 13F CASSAVA SCIENCES COM Call 13,800 91.67 338 95.38 n/a n/a n/a
2023-05-15 2023-03-31 13F CASSAVA SCIENCES COM Call 7,200 174 n/a n/a n/a
2023-02-14 2022-12-31 13F CASSAVA SCIENCES COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2022-11-14 2022-09-30 13F CASSAVA SCIENCES COM Call 5,200 -62.32 217 -44.07 n/a n/a n/a
2022-08-08 2022-06-30 13F CASSAVA SCIENCES COM Call 13,800 388 n/a n/a n/a
2022-05-16 2022-03-31 13F CASSAVA SCIENCES COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2022-02-14 2021-12-31 13F CASSAVA SCIENCES COM Call 8,200 -57.73 358 -70.27 n/a n/a n/a
2021-11-15 2021-09-30 13F CASSAVA SCIENCES COM Call 19,400 6,366.67 1,204 4,530.77 n/a n/a n/a
2021-08-16 2021-06-30 13F CASSAVA SCIENCES COM Call 300 -94.00 26 -88.44 n/a n/a n/a
2021-05-17 2021-03-31 13F CASSAVA SCIENCES COM Call 5,000 225 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-08 2026-03-31 13F FILANA THERAPEUTICS COM Put 63,800 -23.78 108 -35.15 n/a n/a n/a
2026-02-13 2025-12-31 13F CASSAVA SCIENCES COM Put 83,700 -19.44 166 -45.36 n/a n/a n/a
2025-11-14 2025-09-30 13F CASSAVA SCIENCES COM Put 103,900 2.36 302 65.03 n/a n/a n/a
2025-08-13 2025-06-30 13F CASSAVA SCIENCES COM Put 101,500 -8.64 184 10.24 n/a n/a n/a
2025-05-14 2025-03-31 13F CASSAVA SCIENCES COM Put 111,100 -53.96 167 -70.83 n/a n/a n/a
2025-02-13 2024-12-31 13F CASSAVA SCIENCES COM Put 241,300 -23.23 569 -93.85 n/a n/a n/a
2024-11-14 2024-09-30 13F CASSAVA SCIENCES COM Put 314,300 35.36 9,250 222.60 n/a n/a n/a
2024-08-14 2024-06-30 13F CASSAVA SCIENCES COM Put 232,200 26.89 2,868 -22.78 n/a n/a n/a
2024-05-15 2024-03-31 13F CASSAVA SCIENCES COM Put 183,000 23.23 3,713 11.10 n/a n/a n/a
2024-02-14 2023-12-31 13F CASSAVA SCIENCES COM Put 148,500 194.06 3,343 297.86 n/a n/a n/a
2023-11-21 2023-09-30 13F/A CASSAVA SCIENCES COM Put 50,500 3.91 840 -29.47 n/a n/a n/a
2023-11-14 2023-09-30 13F CASSAVA SCIENCES COM Put 50,500 840 n/a n/a n/a
2023-08-14 2023-06-30 13F CASSAVA SCIENCES COM Put 48,600 659.38 1,192 673.38 n/a n/a n/a
2023-05-15 2023-03-31 13F CASSAVA SCIENCES COM Put 6,400 154 n/a n/a n/a
2023-02-14 2022-12-31 13F CASSAVA SCIENCES COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2022-11-14 2022-09-30 13F CASSAVA SCIENCES COM Put 8,300 388.24 347 622.92 n/a n/a n/a
2022-08-08 2022-06-30 13F CASSAVA SCIENCES COM Put 1,700 48 n/a n/a n/a
2022-05-16 2022-03-31 13F CASSAVA SCIENCES COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2022-02-14 2021-12-31 13F CASSAVA SCIENCES COM Put 1,300 -85.56 57 -89.80 n/a n/a n/a
2021-11-15 2021-09-30 13F CASSAVA SCIENCES COM Put 9,000 150.00 559 81.49 n/a n/a n/a
2021-08-16 2021-06-30 13F CASSAVA SCIENCES COM Put 3,600 308 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.